Literature DB >> 20962419

Guidelines for pharmacotherapy of atrial fibrillation (JCS 2008): digest version.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20962419     DOI： 10.1253/circj.cj-88-0001

Source DB:  PubMed          Journal:  Circ J        ISSN： 1346-9843            Impact factor:   2.993


× No keyword cloud information.
  29 in total

1.  Eicosapentaenoic acid for the prevention of recurrent atrial fibrillation.

Authors:  Eiichi Watanabe; Yoshihiro Sobue; Kan Sano; Kentarou Okuda; Mayumi Yamamoto; Yukio Ozaki
Journal:  Ann Noninvasive Electrocardiol       Date:  2011-10       Impact factor: 1.468

Review 2.  The need for multicentre cardiovascular clinical trials in Asia.

Authors:  Joey S W Kwong; Cheuk-Man Yu
Journal:  Nat Rev Cardiol       Date:  2013-04-16       Impact factor: 32.419

3.  Pharmacists' role in handling problems with prescriptions for antithrombotic medication in Belgian community pharmacies.

Authors:  S Desmaele; I De Wulf; A G Dupont; S Steurbaut
Journal:  Int J Clin Pharm       Date:  2015-03-31

Review 4.  Oral anticoagulants for Asian patients with atrial fibrillation.

Authors:  Ian Sabir; Kaivan Khavandi; Jack Brownrigg; A John Camm
Journal:  Nat Rev Cardiol       Date:  2014-03-11       Impact factor: 32.419

5.  Bleeding and related mortality with NOACs and VKAs in newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry.

Authors:  Jean-Pierre Bassand; Saverio Virdone; Marc Badoz; Freek W A Verheugt; A John Camm; Frank Cools; Keith A A Fox; Samuel Z Goldhaber; Shinya Goto; Sylvia Haas; Werner Hacke; Gloria Kayani; Frank Misselwitz; Karen S Pieper; Alexander G G Turpie; Martin van Eickels; Ajay K Kakkar
Journal:  Blood Adv       Date:  2021-02-23

6.  Massive haemoptysis following dabigatran administration in a patient with bronchiectasis.

Authors:  Manabu Hayama; Hideki Inoue; Hiromichi Wada; Tadashi Mio
Journal:  BMJ Case Rep       Date:  2014-02-19

Review 7.  Clinical considerations of anticoagulation therapy for patients with atrial fibrillation.

Authors:  Shu Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2012-08       Impact factor: 3.066

8.  Periprocedural coagulability in patients undergoing ablation of atrial fibrillation: lessons from a periablation anticoagulation strategy of a brief withdrawal of warfarin without heparin bridging.

Authors:  Akinori Sairaku; Yukihiko Yoshida; Haruo Hirayama; Yukiko Nakano; Yasuki Kihara
Journal:  J Thromb Thrombolysis       Date:  2014-05       Impact factor: 2.300

9.  The Association of Cardio-Ankle Vascular Index (CAVI) with Biatrial Remodeling in Atrial Fibrillation.

Authors:  Keijiro Nakamura; Takahito Takagi; Norihiro Kogame; Hikari Hashimoto; Masako Asami; Yasutake Toyoda; Yoshinari Enomoto; Hidehiko Hara; Mahito Noro; Kaoru Sugi; Masao Moroi; Masato Nakamura
Journal:  J Atheroscler Thromb       Date:  2020-08-29       Impact factor: 4.928

10.  Geographic variations in the quality of oral anticoagulation with vitamin k antagonists in the era of new anticoagulants.

Authors:  Laurent Fauchier; Sophie Taillandier
Journal:  J Am Heart Assoc       Date:  2013-02-19       Impact factor: 5.501
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.